Top Innovations Driving the Neurointerventional Device Market By 2023 to 2033

 The global neurointerventional devices market size is projected to be worth USD 2.6 billion in 2023, with projections indicating a market value of approximately USD 4.1 billion by 2033. This expansion is driven by increased healthcare expenditures worldwide and enhanced reimbursement policies for neurointerventional procedures, according to a new market study.

The neurointerventional devices sector, encompassing innovative technologies for treating neurological conditions through minimally invasive procedures, was valued at USD 2.5 billion by the end of 2022. The market is experiencing a compound annual growth rate (CAGR) of 4.3% from 2018 to 2022, with expectations to sustain a robust CAGR of 4.7% from 2023 to 2033.

Key factors contributing to this growth include improved reimbursement policies, which are expected to incentivize healthcare providers to invest in advanced neurointerventional devices. These policies are likely to increase device availability and drive market expansion.

Get Access to Sample Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-871

Key Market Insights:

  • The global neurointerventional devices market is projected to reach USD 4.1 billion by 2033.
  • The market is anticipated to grow at a CAGR of 4.7% from 2023 to 2033.
  • By end-user, the hospitals segment is expected to expand at a CAGR of 4.5% through 2033.
  • The Indian market is forecasted to grow at a CAGR of 4.5% through 2033.

“The digitalization of healthcare records and patient data can facilitate seamless communication between healthcare providers, potentially improving the utilization of neurointerventional devices,” remarks an FMI analyst.

Competitive Landscape:

Prominent players in the neurointerventional devices market include Stryker Corporation, Penumbra Inc., Covidien Public Limited, Johnson & Johnson Private Limited, Terumo Corporation, Medtronic, Boston Scientific, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., Abbott, Philips Healthcare, and Siemens Healthineers.

As the market continues to evolve, key players are expected to focus on expanding their product portfolios and strengthening distribution networks to capitalize on emerging opportunities in this dynamic sector.

Recent Developments:

  • Johnson & Johnson launched the EmboTrap™ II Embolic Capture Device in 2023, designed to enhance stroke treatment.
  • Boston Scientific introduced the ACURUN™ Onyx™ Liquid Embolic System in 2022, targeting vascular malformations and neurovascular disorders.

Market Segmentation:

  • By Product: Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, and more.
  • By Technique: Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures.
  • By End User: Hospitals, Ambulatory Surgical Centers.
  • By Region: North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, The Middle East & Africa.

Comments

Post a Comment

Popular posts from this blog

Technological Advancements Fueling the Physiotherapy Equipment Market By 2023 to 2033

 The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly. The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole. Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Physiotherapy E
Read more

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/samp
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, enc
Read more